These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35850184)

  • 1. Design of nanostructured lipid carriers and solid lipid nanoparticles for enhanced cellular uptake.
    Veider F; Akkuş-Dağdeviren ZB; Knoll P; Bernkop-Schnürch A
    Int J Pharm; 2022 Aug; 624():122014. PubMed ID: 35850184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoarchitectonics of Layer-by-Layer (LbL) coated nanostructured lipid carriers (NLCs) for Enzyme-Triggered charge reversal.
    Akkuş-Dağdeviren ZB; Fürst A; David Friedl J; Tribus M; Bernkop-Schnürch A
    J Colloid Interface Sci; 2023 Jan; 629(Pt A):541-553. PubMed ID: 36088699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphate decorated lipid-based nanocarriers providing a prolonged mucosal residence time.
    Efiana NA; Fürst A; Saleh A; Shahzadi I; Bernkop-Schnürch A
    Int J Pharm; 2022 Sep; 625():122096. PubMed ID: 35963286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charge converting nanostructured lipid carriers containing a cell-penetrating peptide for enhanced cellular uptake.
    Knoll P; Hörmann N; Nguyen Le NM; Wibel R; Gust R; Bernkop-Schnürch A
    J Colloid Interface Sci; 2022 Dec; 628(Pt A):463-475. PubMed ID: 35932682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zeta Potential Changing Polyphosphate Nanoparticles: A Promising Approach To Overcome the Mucus and Epithelial Barrier.
    Akkus ZB; Nazir I; Jalil A; Tribus M; Bernkop-Schnürch A
    Mol Pharm; 2019 Jun; 16(6):2817-2825. PubMed ID: 31070926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming intestinal barriers by heparanase-responsive charge-converting nanocarriers.
    Veider F; Zöller K; Saleh A; Bernkop-Schnürch A
    Int J Pharm; 2024 Feb; 651():123817. PubMed ID: 38237708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyphosphate coatings: A promising strategy to overcome the polycation dilemma.
    Le NN; Steinbring C; Le-Vinh B; Jalil A; Matuszczak B; Bernkop-Schnürch A
    J Colloid Interface Sci; 2021 Apr; 587():279-289. PubMed ID: 33360901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digestion of lipid excipients and lipid-based nanocarriers by pancreatic lipase and pancreatin.
    Zöller K; To D; Knoll P; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2022 Jul; 176():32-42. PubMed ID: 35584719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and Evaluation of Charge Reversal Solid Lipid Nanoparticles.
    Federer C; Spleis HV; Summonte S; Friedl JD; Wibel R; Bernkop-Schnürch A
    J Pharm Sci; 2022 Aug; 111(8):2270-2279. PubMed ID: 35235841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.
    Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M
    Daru; 2011; 19(1):23-32. PubMed ID: 22615636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin-Loaded Solid Lipid Nanoparticle Dispersion with Improved Physicochemical Properties and Cellular Uptake.
    Vijayakumar A; Baskaran R; Jang YS; Oh SH; Yoo BK
    AAPS PharmSciTech; 2017 Apr; 18(3):875-883. PubMed ID: 27368922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral drug delivery: Influence of mucus on cellular interactions and uptake of lipid-based nanocarriers in Caco-2 cells.
    Veider F; Knoll P; Jörgensen AM; Stengel D; Bernkop-Schnürch A
    Acta Biomater; 2023 Sep; 167():416-424. PubMed ID: 37311506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatase-degradable nanoparticles providing sustained drug release.
    Summonte S; Sanchez Armengol E; Ricci F; Sandmeier M; Hock N; Güclü-Tuncyüz A; Bernkop-Schnürch A
    Int J Pharm; 2024 Apr; 654():123983. PubMed ID: 38460768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophilic coating of mitotane-loaded lipid nanoparticles: preliminary studies for mucosal adhesion.
    Severino P; Souto EB; Pinho SC; Santana MH
    Pharm Dev Technol; 2013; 18(3):577-81. PubMed ID: 21958059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.
    Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O
    Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Size shifting of solid lipid nanoparticle system triggered by alkaline phosphatase for site specific mucosal drug delivery.
    Le-Vinh B; Steinbring C; Wibel R; Friedl JD; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2021 Jun; 163():109-119. PubMed ID: 33775852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide Antibiotic-Polyphosphate Nanoparticles: A Promising Strategy to Overcome the Enzymatic and Mucus Barrier of the Intestine.
    Saleh A; Akkuş-Dağdeviren ZB; Haddadzadegan S; Wibel R; Bernkop-Schnürch A
    Biomacromolecules; 2023 Jun; 24(6):2587-2595. PubMed ID: 37224061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations.
    Mura P; Maestrelli F; D'Ambrosio M; Luceri C; Cirri M
    Pharmaceutics; 2021 Mar; 13(4):. PubMed ID: 33804945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin.
    Han Y; Zhang Y; Li D; Chen Y; Sun J; Kong F
    Int J Nanomedicine; 2014; 9():4107-16. PubMed ID: 25187713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid nanocarriers diffuse effectively through mucus and enter intestinal cells - but where is my peptide?
    Dumont C; Beloqui A; Miolane C; Bourgeois S; Préat V; Fessi H; Jannin V
    Int J Pharm; 2020 Aug; 586():119581. PubMed ID: 32603838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.